iMD Companies, Inc. (ICBU)
OTCMKTS · Delayed Price · Currency is USD
0.0012
+0.0001 (9.09%)
Oct 17, 2025, 3:59 PM EDT
iMD Companies Market Cap
iMD Companies has a market cap or net worth of $5.79 million as of October 17, 2025. Its market cap has decreased by -60.44% in one year.
Market Cap
5.79M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 15, 2008, iMD Companies's market cap has decreased from 99.51M to 5.79M, a decrease of -94.18%. That is a compound annual growth rate of -15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 5.79M | -40.53% |
| Dec 31, 2024 | 9.74M | 506.15% |
| Dec 29, 2023 | 1.61M | -18.58% |
| Dec 30, 2022 | 1.97M | -73.55% |
| Dec 31, 2021 | 7.46M | 235.46% |
| Dec 31, 2020 | 2.22M | 135.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |